International Scientific Congress for Students, Young Physicians and Pharmacists Marisiensis 2014.

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

CASE Mrs Ford is a 29 years old lady who has been complaining of vaginal discharge for the past 3 days. Otherwise she is asymptomatic. Her PMH includes.
Instructions and Reporting Requirements Module 2 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Cervical Screening Guidelines - for now and the future - Meg McLachlin, MD, FRCPC.
MANAGEMENT OF ABNORMAL PAP SMEAR
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
How to do cervical pap smear
Cervical Cancer DR KHALID H. WALI SAIT (FRCSC) ASSOCIATE PROFESSOR OF GYNECOLOGICAL ONCOLOGY King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Vaginitis and PID – The Basics Wanda Ronner, M.D..
Speaker: Decca Mohammed, MD.  Statistics for cervical cancer and HPV  Association of HPV to cervical cancer, and other cancers  Prevention  Screening.
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
Sample Taker Training Cervical Cytology & Management of Abnormalities.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Vaginitis and PID Wanda Ronner, M.D.. Vaginitis Disruption in the normal vaginal ecosystem Alteration of vaginal pH A decrease in lactobacilli Growth.
Benign and premalignant disease of the cervix
Jacqueline Castagno, MD FACOG Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Florida College of Medicine.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
F UNGAL G ENITOURINARY S YSTEM I NFECTIONS. Bladder and kidneys infections Valvovaginal infections.
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
Cervical Cancer Screening
Swabs Skill 304 Dr. Mohammad Marie Lecture \ 5.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Screening Tests for Brest & Cervical Cancer
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
The Nature of Disease.
Human Biology Sylvia S. Mader Michael Windelspecht
SoftPAP® A Novel Collection Device for Cervical Cytology.
TEAM CASE STUDY 3. EUKARYOTIC – PROTOZOA.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
Hot Topics Clinical Medicine ACHA Annual Meeting Boston, MA May 31, 2013.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
STD Surveillance Network (SSuN) Cycle 2 Objectives Lori Newman & Kristen Mahle SSuN Principal Collaborators Meeting Atlanta, GA December 2, 2008.
AGE DIFFERENCE IN CERVICAL NEOPLASIA DISTRIBUTION AMONG WOMEN ATTENDING A HOSPITAL BASED AND PERIPHERAL SCREENING PROGRAMMES Dr.Kalavathy Mathurchennath1,
Cervical Intraepithelial Neoplasm
Top Pap smear Questions. 1-When should Pap screening begin? Age 21 y/o,3yrs after first intercourse.
Marisiensis 2014 INFECTIONS IN PRETERM BIRTH COORDINATOR: Asist. Univ. Dr. OVIDIU GRAMA First author: Farcas Marcela Leontina Authors: Clapon Anca, Roman.
Syndromes.
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
Cervical Cancer Screening and Sexually Transmitted Infections Case Studies.
Cervical Cancer Screening and Sexually Transmitted Infection Case Study PCP version
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
Epidemiology of STD. Change in incidence (simple access to antibiotic, change to sexual behavior, multiple partner, low age of sexual contact, addiction,
Development of Nano-based technology for differential temperature detection of early malignant lesion Nor Hayati Othman, Pathology dept, PPSP
Genital Tract Infection
Cytopathology Feb
Vaginal discharge culture
Characterstic of disease
Contact: PRELIMINARY RESULTS OF FIRST HPV PRIMARY SCREENING PRIVATE SECTOR IN BUENOS AIRES FEMALE POPULATION R. Jiménez del Toro,
Vaginal Infections NURS 541: Women’s Healthcare – Diagnosis and Management.
Specialty Doctor in Sexual Health
LIQUID-BASED CYTOLOGY AND HPV DNA DETECTION
Dr.Jyothi Ranganathan Head lab operations SRL Ltd Bangalore
Cervical Cancer Tiffany Smith HCP 102.
Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.
Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
F.Behnamfar Gynecology Oncology Fellow Professor
How do we delay disease progress once it has started?
Introduction To Medical Technology
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
WOMEN’S HEALTH Sexually Transmitted Infections & Cervical Screening
Epidemiology of cervical cancer in India: Where do we stand today
Presentation transcript:

International Scientific Congress for Students, Young Physicians and Pharmacists Marisiensis 2014

 Interest in the microflora of the vagina and cervix has stemmed from the recognition of its significant association with vaginal and upper genital tract infections. Yet a clear understanding of the range of microbial types which are consistent with a normal genital tract and the factors which control the flora are elusive.

 Cervico-vaginal infection is one of the most common problems in clinical medicine. Although the cytologic evaluation reveals a wide range of tissue modifications caused by multiple factors ( microorganism infections), usually, the cause of these changes is HPV infection. In most cases these changes in the tissue structure are reversible, still they can lead to cancer development.

 Acute vaginitis is one of the most common diseases seen in the practice of office gynecology. Large survey studies of women with lower genital tract symptoms suggestive of vaginitis have demonstrated the presence of three major etiologic categories in acute vaginitis: (1) nonspecific vaginosis (Gardnerella vaginalis), (2) vulvovaginal candidiasis (Candida albicans), and (3) trichomoniasis (Trichomonas vaginalis). Effective treatment of acute vaginitis requires that an accurate diagnosis be established and etiologic microorganism(s) be identified

 Our aim was to determine the prevalence of pathogenic microorganisms infections in cervicovaginal smears.

 It was a retrospective study including 250 cytodiagnosis reports between March 2011 and March Of the patients included 32% were menopausal, 25% pregnant and 40% in normal menstrual period.

 We collected data from any patient who had a pap smear during this period of time in an private practice in Radauti. Vaginal examination and taken smear was carried out by physician. The smears were fixed with methanol and send to clinical pathology laboratory. The smears were evaluated by a pathologist.

 This information includes the sample adequacy, the type of (e.g. squamous, glandular, and metaplastic), benign cellular alterations (e.g. infl ammation), and the type of genital infections (e.g. T. vaginalis and Candida sp).

 Performing a detailed analysis on the data we received we found that the frequencies of the pathogenic microorganisms were as follow:

 We also confirmed a relation between the presence of Candida and the benigne modifications of the tissue prelevated by creating and analysing a contingency table.

 We statistically proved that Candida infection affects in equal proportion women in non- menopausal group rather than the meopausal one

 Although, our study is confirmed by publications which indicate that candidiasis is the most common vaginal infection in most countries, but the prevalence rate of infective agents obtained from the current study was lower in comparison with other studies  The current study showed that the highest prevalence rate of Candida (34%) was seen in the non-menopausal group.

 This study showed that the proportion of women with LSIL (4,4%) and HSIL (2,8%) was low. This result was obtained by cytology tests and furthermore these findings were associated with the presence of type 16, 18 and 35 HPV.

Infections can be diagnosed in cervical smears through identification either of the organism or of characteristic cytological cellular changes. Moreover, vaginal infections produced by drug resistance of infectious agents should be noticed in treatment.

 Trichomonas, Candida, and Gardnerella in Cervical Smears of Iranian Women for Cancer Screening Narges Kalantari, Salman Ghaffari1, Masomeh Bayani2  Importance of differential diagnosis in acute vaginitis. Am J Obstet Gynecol Aug 1;152(7 Pt 2):  Bacteriology of the vagina. Scand J Urol Nephrol Suppl. 1984;86:  Trichomonas, Candida, and gardnerella in cervical smears of Iranian women for cancer screening. N Am J Med Sci Jan;6(1):25-9. doi: /  Prevalence of cervical-vaginal infections in the pap-smear samples in Iran. Glob J Health Sci Dec 19;6(1): doi: /gjhs.v6n1p201.  Epidemiologic differences between candidial and trichomonal infections as detected in cytologic smears in Taiwan. Public Health.1995 Nov;109(6):  Prevalence of high-grade cervical lesion in women with LSIL and HSIL cytology and prevalence of invasive cancer in women cytologically positive for malignancy.  Asian Pac J Cancer Prev Oct-Dec;9(4):715-8.